Millions of Americans are rapidly shedding pounds using Ozempic, Wegovy and similar drugs, fueling what many are calling a weight-loss revolution.

“GLP-1s have become the single biggest drug launch that we have ever seen,” said Harith Rajagopalan, CEO of Fractyl Health. “There are 10 million people who are on a GLP-1 this year. Projections are that 30 million people will be on GLP-1s in the next five years.”

Stream NBC10 Boston news for free, 24/7, wherever you are. WATCH HERE

At Fractyl Health, Rajagopalan leads a team of scientists working to target the root causes of obesity and Type 2 diabetes, rather than simply controlling symptoms.

“We think that you can deliver better outcomes for people if you fix the root cause of obesity so that people can live a life that is free of dise

See Full Page